Citi downgraded QuidelOrtho (QDEL) to Neutral from Buy with a price target of $33, down from $40. The firm cites a lack of upside to the company’s mid-single-digit growth outlook for the downgrade. Citi sees challenges with the LEX launch and higher interest expense pressuring QuidelOrtho’s fiscal 2025 earnings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: